Gabelli Healthcare (NYSE:GRX) Receiving Somewhat Positive News Coverage, Accern Reports

News headlines about Gabelli Healthcare (NYSE:GRX) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Gabelli Healthcare earned a news impact score of 0.24 on Accern’s scale. Accern also gave news articles about the investment management company an impact score of 48.0863244335902 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Shares of NYSE GRX opened at $9.37 on Monday. Gabelli Healthcare has a 12-month low of $9.12 and a 12-month high of $10.97.

How to Become a New Pot Stock Millionaire

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 22nd. Stockholders of record on Thursday, March 15th were paid a dividend of $0.13 per share. The ex-dividend date of this dividend was Wednesday, March 14th. This represents a $0.52 annualized dividend and a dividend yield of 5.55%.

WARNING: “Gabelli Healthcare (NYSE:GRX) Receiving Somewhat Positive News Coverage, Accern Reports” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at

Gabelli Healthcare Company Profile

There is no company description available for Gabelli Healthcare & WellnessRx Trust.

Insider Buying and Selling by Quarter for Gabelli Healthcare (NYSE:GRX)

Receive News & Ratings for Gabelli Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gabelli Healthcare and related companies with's FREE daily email newsletter.

Leave a Reply